Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Microbiol.

Sec. Infectious Agents and Disease

Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1624387

CD155 as a Therapeutic Target in Alveolar Echinococcosis: Insights from an E. multilocularis Infection Mouse Model

Provisionally accepted
Xue  ZhangXue Zhang1Liang  LiLiang Li2Tao  SunTao Sun2Ning  YangNing Yang1Hui  LiuHui Liu1Jin  ChuJin Chu1Junlong  XueJunlong Xue2GUODONG  LYUGUODONG LYU1Tuerganaili  AjiTuerganaili Aji3*Xiaojuan  BiXiaojuan Bi1*Renyong  LinRenyong Lin1*
  • 1Clinical Medical Research Institute, Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases, Xinjiang Medical University, Urumqi, China
  • 2Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases, Xinjiang Medical University, Urumqi, China
  • 3Department of Hepatobiliary and Hydatid Diseases, Digestive and Vascular Surgery Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China

The final, formatted version of the article will be published soon.

Introduction: Alveolar echinococcosis (AE) is a life-threatening zoonotic parasitic disease caused by the metacestode form of Echinococcus multilocularis (E. multilocularis), characterized by granulomatous lesions and liver fibrosis. Immune exhaustion is the main mechanism by which E. multilocularis evades host immune responses and sustains long-term parasitism. Although cluster differentiation 155 (CD155) is recognized as an immune checkpoint molecule, its specific role and mechanism in AE remain unclear. Methods: The E. multilocularis infection mouse model was used to investigate the role of CD155 in AE progression. Flow cytometry, immunohistochemistry, and immunofluorescence were employed to assess CD155 expression and analyze T-cell function. Hematoxylin and eosin staining was used to evaluate pathological changes.Results: In E. multilocularis-infected group, we observed a significant upregulation of CD155 expression on hepatocytes adjacent to the lesions. Furthermore, we identified a notable impairment in the functionality of CD4 + and CD8 + T cells, accompanied by an enrichment of exhausted TIGIT + cells in the vicinity of CD155 + cells. Moreover, CD155 expression was significantly upregulated on hepatocytes co-cultured with metacestode vesicles in vitro. Notably, CD155 knockout in hepatocytes within the E. multilocularis infection mouse model reversed the exhaustion state in CD4 + and CD8 + T cells. Conclusions: In E. multilocularis infection mouse model, excretory/secretory products from metacestode vesicles upregulated CD155 expression in hepatocytes, thereby sustaining an immunosuppressive microenvironment. Hepatocyte-specific knockout of CD155 reversed immune exhaustion and significantly reduced lesion number and size. These findings establish CD155 as a promising therapeutic target for E. multilocularis infections.

Keywords: Echinococcus multilocularis1, CD1552, T-cell exhaustion3, Alveolar echinococcosis4, Metacestode vesicles5

Received: 07 May 2025; Accepted: 18 Jun 2025.

Copyright: © 2025 Zhang, Li, Sun, Yang, Liu, Chu, Xue, LYU, Aji, Bi and Lin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Tuerganaili Aji, Department of Hepatobiliary and Hydatid Diseases, Digestive and Vascular Surgery Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
Xiaojuan Bi, Clinical Medical Research Institute, Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases, Xinjiang Medical University, Urumqi, China
Renyong Lin, Clinical Medical Research Institute, Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases, Xinjiang Medical University, Urumqi, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.